CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in CalciMedica, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −13 vs. Q2 2021
- Shares held
- 11.2M
- −535.6K (−4.6%) vs. Q2 2021
- Total value
- $37.0M
- −$26.4M (−41.6%) vs. Q2 2021
- New holders
- 4
- 3 more added
- Sold out
- 17
- 12 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CALC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $8.39M |
| Q1 2026 | 27 | $592.5K |
| Q4 2025 | 31 | $24.2M |
| Q3 2025 | 31 | $10.9M |
| Q2 2025 | 30 | $5.93M |
| Q1 2025 | 30 | $7.49M |
| Q4 2024 | 29 | $15.1M |
| Q3 2024 | 24 | $13.6M |
| Q2 2024 | 21 | $11.8M |
| Q1 2024 | 20 | $14.8M |
| Q4 2023 | 12 | $1.49M |
| Q3 2023 | 13 | $1.56M |
| Q2 2023 | 13 | $2.72M |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 27 | $5.97M |
| Q3 2022 | 25 | $10.2M |
| Q2 2022 | 25 | $11.7M |
| Q1 2022 | 27 | $13.5M |
| Q4 2021 | 28 | $20.7M |
| Q3 2021 | 27 | $37.0M |
| Q2 2021 | 41 | $63.7M |
| Q1 2021 | 51 | $72.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding CalciMedica, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 5,281,713 | $17.5M | 0.34% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,163,347 | $13.8M | 0.15% | 00.0% | Unchanged |
| Vanguard Group Inc | 432,795 | $1.44M | 0.00% | +2,408+0.6% | Added |
| Morgan Stanley | 305,948 | $1.02M | 0.00% | −303,464−49.8% | Reduced |
| First Manhattan Co | 292,003 | $969.0K | 0.00% | 00.0% | Unchanged |
| Sculptor Capital LP | 130,900 | $435.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 107,765 | $358.0K | 0.00% | +107,765 | New |
| Bridgeway Capital Management, LLC | 90,000 | $299.0K | 0.01% | +90,000 | New |
| Citadel Advisors LLC | 81,568 | $271.0K | 0.00% | +81,568 | New |
| Geode Capital Management, LLC | 57,647 | $191.0K | 0.00% | −12,735−18.1% | Reduced |
| Johnson & Johnson | 49,547 | $164.0K | 0.01% | +49,547 | New |
| Susquehanna International Group, LLP | 48,984 | $162.0K | 0.00% | −219,799−81.8% | Reduced |
| BlackRock Inc. | 33,225 | $110.0K | 0.00% | −692−2.0% | Reduced |
| State Street Corp | 20,548 | $68.0K | 0.00% | −20,625−50.1% | Reduced |
| Northern Trust Corp | 16,104 | $53.0K | 0.00% | +4,147+34.7% | Added |
| Brown Advisory Inc | 13,867 | $46.0K | 0.00% | −2,466−15.1% | Reduced |
| Simplex Trading, LLC | 8,176 | $42.0K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 10,219 | $34.0K | 0.00% | −9,310−47.7% | Reduced |
| Advisor Group Holdings, Inc. | 4,250 | $14.0K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 3,330 | $11.0K | 0.00% | −1,870−36.0% | Reduced |
| Spire Wealth Management | 1,200 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 823 | $3.00K | 0.00% | −12,283−93.7% | Reduced |
| Royal Bank of Canada | 1,000 | $3.00K | 0.00% | −466−31.8% | Reduced |
| Point72 Hong Kong Ltd | 197 | $1.00K | 0.00% | −3,303−94.4% | Reduced |
| UBS Group AG | 209 | $1.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 15 | $0 | 0.00% | −807−98.2% | Reduced |
| Wells Fargo & Company | 80 | $0 | 0.00% | +42+110.5% | Added |
| Virtu Financial LLC | 0 | $0 | 0.00% | −65,899−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −28,220−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −26,941−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −23,432−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −23,165−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −20,345−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −17,700−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −17,484−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −17,580−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −15,870−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −12,305−100.0% | Sold out |
| Alta Wealth Advisors LLC | 0 | $0 | 0.00% | −10,771−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,221−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −635−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −631−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −66−100.0% | Sold out |
| Johnson & Johnson Innovation - JJDC, Inc. | – | – | – | – | Not filed |